Companies: 10,795·Total market cap: $144.5T
IDEAYA Biosciences, Inc.

IDEAYA Biosciences, Inc.

IDYANASDAQHealthcare● Active
$31.48
+$3.19(+11.28%)
Market Cap$2.8B
P/E Ratio
52W High$39.28
52W Low$20.5
Overview

IDEAYA Biosciences, Inc. (IDYA) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · IDYA · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-1.58idya eps ttm · idya earnings per shareEarnings history
PE Ratio (TTM)idya pe ratio ttm · idya price to earningsPE Ratio deep dive
Revenue (TTM)$225.3Midya revenue ttm · idya annual revenueFull revenue history
Dividend YieldNo Dividenddoes idya pay dividends · idya dividend yieldDividend history
Shares Outstanding88.5Midya shares outstanding · idya floatShares outstanding history
Next EarningsAug 4, 2026Est.idya earnings date · idya next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$218.7M▲ +3024.43% YoY
202320242025
ideaya biosciences, inc. revenue · idya revenue 2025
FY 2025Net Income-$113.7M▲ +58.58% YoY
202320242025
ideaya biosciences, inc. net income · idya profit 2025
FY 2025EPS$-1.28▲ +61.90% YoY
202320242025
idya eps · ideaya biosciences, inc. earnings per share 2025
TTM:Revenue: $225.3MNet Income: -$140.1MEPS: $-1.58View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy25 analystsis idya a buy · idya analyst rating
Strong Buy
0
Buy
23
Hold
2
Sell
0
Strong Sell
0
12-Month Price Target
$53.00Low
$31.48Current
$58.67Avg Target86.37% upside
$65.00High
idya price target · idya 12 month forecast

Total: 25 · Buy rate: 92.0%

The IDYA analyst consensus is Buy, based on ratings from 25 Wall Street analysts over the past 3 months. The average 12-month price target is $58.67, representing +86.37% upside from the current price of $31.48.

Stock Performance

Full History
1D-3.18%
1W+1.84%
1M-0.11%
3M-14.76%
YTD-18.17%
1Y+30.31%
5Y+29.53%

About IDEAYA Biosciences, Inc.

CEOYujiro S. Hata
IPO DateMay 23, 2019
Employees131
CountryUS

IDEAYA Biosciences, Inc. is a precision oncology company primarily dedicated to identifying and advancing targeted therapies, particularly leveraging the concept of synthetic lethality. The firm aims …

what is ideaya biosciences, inc. · idya stock overview · ideaya biosciences, inc. company profile · who is ideaya biosciences, inc. ceo · idya NASDAQ · ideaya biosciences, inc. headquarters · ideaya biosciences, inc. business segments

About Stock Overview & Key Data

IDEAYA Biosciences, Inc. (IDYA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since May 23, 2019. As of the latest trading session, IDYA stock price is $31.48, with a market capitalization of $2.8B. The stock has returned +30.31% over the past 12 months and -18.17% year-to-date.

According to 25 Wall Street analysts, the consensus rating for IDEAYA Biosciences, Inc. stock is Buy, with an average 12-month price target of $58.67. In fiscal year 2025, IDEAYA Biosciences, Inc. reported revenue of $218.7M and net income of -$113.7M. For detailed data — including IDEAYA Biosciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, IDEAYA Biosciences, Inc. (IDYA) stock price is $31.48. The stock is traded on NASDAQ under the ticker symbol IDYA. The 52-week range is $20.50 – $39.28.

IDYA stock priceIDYA quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice